Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Johann Then has worked on the following 17 EPO patent applications which have been published in the last five years:

EP11729733

HEXAFLUOROISOPROPYL CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

IPC classification:
A61K 31/4468, A61P 25/00, C07D 205/04, C07D 207/12, C07D 207/14, C07D 211/16, C07D 211/46, C07D 211/54, C07D 211/58, C07D 211/62, C07D 401/12, C07D 403/04, C07D 405/12, C07D 409/12, C07D 413/12
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Agent:
Mylène Audrey Séverine Quellari, Sanofi, S.A.
Status:
PATENT GRANTED
EP13151034

Oxazolopyrimidines as Edg-1 receptor agonists

IPC classification:
A61K 31/519, A61P 9/10, C07D 498/04, C07D 519/00
Applicant:
Sanofi, S.A.
Agent:
Multiple attorneys, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP11733622

ARYLOXY-ALKYLENE SUBSTITUTED HYDROXYPHENYL HEXYNOIC ACIDS, METHODS FOR THE PRODUCTION THEREOF AND USE OF THE SAME AS MEDICAMENT

IPC classification:
A61K 31/192, A61K 31/44, C07C 59/64, C07C 255/54, C07D 213/65
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION WITHDRAWN
EP12790551

CRYSTALLINE SALTS OF R)-3-[6-AMINO-PYRIDIN-3-YL]-2-(1-CYCLOHEXYL-1H-IMIDAZOL-4-YL)-PROPIONIC ACID

IPC classification:
A61K 31/4439, A61P 7/02, C07D 401/06
Applicant:
Sanofi, S.A.
Agent:
Michalski Hüttermann & Partner
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12791162

SODIUM SALT OF (R)-3-[6-AMINO-PYRIDIN-3-YL]-2-(1-CYCLOHEXYL-1H-IMIDAZOL-4-YL)-PROPIONIC ACID

IPC classification:
A61K 31/4439, A61P 7/02, C07D 401/06
Applicant:
Sanofi, S.A.
Agent:
Michalski Hüttermann & Partner
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12788550

SALT OF (R)-3-(6-AMINO-PYRIDIN-3-YL)-2-(1-CYCLOHEXYL-1H-IMIDAZOL-4-YL) ETHYL PROPIONATE

IPC classification:
A61K 31/4439, A61P 7/02, C07D 401/06
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13305762

Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9

IPC classification:
C07K 16/40
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION REFUSED
EP13306436

Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9

IPC classification:
A61K 39/00, C07K 16/40
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
APPLICATION REFUSED
EP11700404

CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING

IPC classification:
A61K 31/519, A61P 9/00, C07D 498/04
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11700136

HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES HAVING A 2,5,7-SUBSTITUTED OXAZOLOPYRIMIDINE RING

IPC classification:
A61K 9/00, A61K 31/519, C07D 498/04
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11700403

2,5,7-SUBSTITUTED OXAZOLOPYRIMIDINE DERIVATIVES

IPC classification:
A61K 31/519, A61P 9/00, C07D 498/04
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11700339

HETEROCYCLIC CARBOXYLIC ACID DERIVATIVES HAVING A 2,5-SUBSTITUTED OXAZOLOPYRIMIDINE RING

IPC classification:
A61K 31/519, A61P 9/00, C07D 498/04
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11700098

CARBOXYLIC ACID DERIVATIVES HAVING A 2,5,7-SUBSTITUTED OXAZOLOPYRIMIDINE RING

IPC classification:
A61K 31/519, A61P 3/10, A61P 7/02, A61P 9/00, A61P 11/00, A61P 13/12, A61P 25/28, A61P 29/00, A61P 31/02, A61P 35/00, C07D 498/04
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11731315

(2-ARYLOXY-ACETYLAMINO)-PHENYL-PROPIONIC ACID DERIVATIVES AND THEIR USE AS MEDICAMENT

IPC classification:
A61K 31/196, A61K 31/277, A61P 3/10, C07C 235/24, C07C 255/44
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11779661

PROCESS FOR THE PREPARATION OF 3-(6-AMINO-PYRIDIN-3YL)-2-ACRYLIC ACID DERIVATIVES

IPC classification:
C07D 233/64, C07D 233/84
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11729315

SPIROCYCLICALLY SUBSTITUTED 1,3-PROPANE DIOXIDE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF AND USE OF THE SAME AS MEDICAMENT

IPC classification:
A61K 31/192, A61K 31/34, A61K 31/381, A61K 31/421, A61K 31/426, A61K 31/4439, C07C 59/72, C07C 255/54, C07D 213/64, C07D 213/65, C07D 305/06
Applicant:
Sanofi, S.A.
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11700529

2,5-SUBSTITUTED OXAZOLOPYRIMIDINE DERIVATIVES AS EDG-1 AGONISTS

IPC classification:
A61K 31/519, A61P 9/00, C07D 498/04
Applicant:
Sanofi, S.A.
Applicant:
Sanofi
Agent:
Michalski Hüttermann & Partner
Agent:
Johann Then, Sanofi-Aventis Deutschland GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature